Radical-Intent Hypofractionated Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer: A Systematic Review of the Literature-Reference-Cited by-同舟云学术

Radical-Intent Hypofractionated Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer: A Systematic Review of the Literature

Published:2015-03 Issue:2 Volume:16 Page:71-79
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Kaster Tyler S.,Yaremko Brian,Palma David A.,Rodrigues George B.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference67 articles.

1. National Cancer Institute. SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/statfacts/html/lungb.html.

2. Role of postoperative radiotherapy in resected non–small cell lung cancer: a reassessment based on new data;Le Pechoux;Oncologist,2011

3. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non–oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group;Perez;Cancer,1980

4. Sequential vs. concurrent chemoradiation for stage III non–small cell lung cancer: randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

5. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non–small cell lung cancer: results on radiation dose in RTOG 0617;Bradley;J Clin Oncol,2013

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicenter, Randomized Phase 3 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Neue radioonkologische Therapiekonzepte beim nicht metastasierten Lungenkarzinom;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2024-08

3. Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 2. Lung (non-small cell lung cancer);Radiation Oncology Journal;2024-06-30

4. Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049);International Journal of Radiation Oncology*Biology*Physics;2023-10

5. Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study;Radiation Oncology;2023-08-24